|
1
|
Hernandez-Gea V and Friedman SL:
Pathogenesis of liver fibrosis. Annu Rev Pathol. 6:425–456. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Novo E, Cannito S, Paternostro C, Bocca C,
Miglietta A and Parola M: Cellular and molecular mechanisms in
liver fibrogenesis. Arch Biochem Biophys. 548:20–37. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoshida K, Murata M, Yamaguchi T and
Matsuzaki K: TGF-β/Smad signaling during hepatic
fibro-carcinogenesis (review). Int J Oncol. 45:1363–1371. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sa Y, Li C, Li H and Guo H: TIMP-1 Induces
α-Smooth muscle actin in fibroblasts to promote urethral scar
formation. Cell Physiol Biochem. 35:2233–2243. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bi WR, Yang CQ and Shi Q: Transforming
growth factor-β1 induced epithelial-mesenchymal transition in
hepatic fibrosis. Hepatogastroenterology. 59:1960–1963.
2012.PubMed/NCBI
|
|
6
|
Okazaki I, Noro T, Tsutsui N, Yamanouchi
E, Kuroda H, Nakano M, Yokomori H and Inagaki Y: Fibrogenesis and
carcinogenesis in non-alcoholic steatohepatitis (NASH): Involvement
of matrix metalloproteinases (MMPs) and tissue inhibitors of
metalloproteinase (TIMPs). Cancers Basel). 6:1220–1255. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Poelstra K: Liver fibrosis in 2015:
Crucial steps towards an effective treatment. Nat Rev Gastroenterol
Hepatol. 13:67–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tacke F and Trautwein C: Mechanisms of
liver fibrosis resolution. J Hepatol. 63:1038–1039. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Shen RW, Han B, Li Z, Xiong L,
Zhang FY, Cong BB and Zhang B: Notch signaling mediated by
TGF-β/Smad pathway in concanavalin A-induced liver fibrosis in
rats. World J Gastroenterol. 23:2330–2336. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aimaiti Y, Jin X, Wang W, Chen Z and Li D:
TGF-β1 signaling regulates mouse hepatic stellate cell
differentiation via the Jagged1/Notch pathway. Life Sci.
192:221–230. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen YX, Weng ZH, Qi D and Zhang SL:
Effect of Notch signaling on the activation of hepatic stellate
cells. Zhonghua Gan Zang Bing Za Zhi. 20:677–682. 2012.(In
Chinese). PubMed/NCBI
|
|
12
|
Zhang K, Zhang YQ, Ai WB, Hu QT, Zhang QJ,
Wan LY, Wang XL, Liu CB and Wu JF: Hes1, an important gene for
activation of hepatic stellate cells, is regulated by Notch1 and
TGF-β/BMP signaling. World J Gastroenterol. 21:878–887. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu M, Ou-Yang HF, Wu CG, Qu SY, Xu XT and
Wang P: Notch signaling regulates col1α1 and col1α2 expression in
airway fibroblasts. Exp Biol Med (Maywood. 239:1589–1596. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma PC, Rould MA, Weintraub H and Pabo CO:
Crystal structure of MyoD bHLH domain-DNA complex: Perspectives on
DNA recognition and implications for transcriptional activation.
Cell. 77:451–459. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iso T, Kedes L and Hamamori Y: HES and
HERP families: Multiple effectors of the Notch signaling pathway. J
Cell Physiol. 194:237–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kobayashi T and Kageyama R: Expression
dynamics and functions of Hes factors in development and diseases.
Curr Top Dev Biol. 110:263–283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tomita N, Ogihara T and Morishita R:
Transcription factors as molecular targets: Molecular mechanisms of
decoy ODN and their design. Curr Drug Targets. 4:603–608. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tomita N, Azuma H, Kaneda Y, Ogihara T and
Morishita R: Gene therapy with transcription factor decoy
oligonucleotides as a potential treatment for cardiovascular
diseases. Curr Drug Targets. 4:339–346. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jia D, Ni YR, Zhang YQ, Rao C, Hou J, Tang
HQ, Liu CB and Wu JF: SP1 and UTE1 Decoy ODNs inhibit activation
and proliferation of hepatic stellate cells by targeting tissue
inhibitors of metalloproteinase 1. Cell Biosci. 6:312016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Krizhanovsky V, Yon M, Dickins RA, Hearn
S, Simon J, Miething C, Yee H, Zender L and Lowe SW: Senescence of
activated stellate cells limits liver fibrosis. Cell. 134:657–667.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li YH, Woo SH, Choi DH and Cho EH:
Succinate causes α-SMA production through GPR91 activation in
hepatic stellate cells. Biochem Biophys Res Commun. 463:853–858.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Blokzijl A, Dahlqvist C, Reissmann E, Falk
A, Moliner A, Lendahl U and Ibáñez CF: Cross-talk between the Notch
and TGF-beta signaling pathways mediated by interaction of the
Notch intracellular domain with Smad3. J Cell Biol. 163:723–728.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu L, Gao C, Chen G, Li X, Li J, Wan Q
and Xu Y: Notch signaling molecules activate TGF-β in rat Mesangial
cells under high glucose conditions. J Diabetes Res.
2013:9797022013. View Article : Google Scholar : PubMed/NCBI
|
